These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7276943

  • 21. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS, Runice C, Dowd F.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [Abstract] [Full Text] [Related]

  • 22. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 23. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 24. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G, Norman AB, Hess EJ, Creese I.
    J Neurochem; 1986 Apr 09; 46(4):1180-5. PubMed ID: 3005508
    [Abstract] [Full Text] [Related]

  • 25. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB, Lawlor M, Dunne A, O'Boyle KM.
    J Neurochem; 1995 Sep 09; 65(3):1124-30. PubMed ID: 7643090
    [Abstract] [Full Text] [Related]

  • 26. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE, Gommeren W.
    J Neurochem; 1981 Jan 09; 36(1):201-19. PubMed ID: 7463046
    [Abstract] [Full Text] [Related]

  • 27. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors.
    Makman MH, Dvorkin B, Horowitz SG, Thal LJ.
    Eur J Pharmacol; 1980 May 02; 63(2-3):217-22. PubMed ID: 6155277
    [Abstract] [Full Text] [Related]

  • 28. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH, Dvorkin B, Horowitz SG, Thal LJ.
    Brain Res; 1980 Aug 04; 194(2):403-18. PubMed ID: 6770965
    [Abstract] [Full Text] [Related]

  • 29. 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium.
    Hamblin MW, Creese I.
    Life Sci; 1982 May 03; 30(18):1587-95. PubMed ID: 7078356
    [Abstract] [Full Text] [Related]

  • 30. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
    Williams M, Totaro JA.
    Eur J Pharmacol; 1982 Dec 17; 86(1):35-42. PubMed ID: 7160432
    [Abstract] [Full Text] [Related]

  • 31. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D, Seeman P.
    J Neurochem; 1985 Jun 17; 44(6):1925-35. PubMed ID: 3157782
    [Abstract] [Full Text] [Related]

  • 32. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
    Kilpatrick GJ, Jenner P, Marsden CD.
    J Neurochem; 1986 Feb 17; 46(2):413-21. PubMed ID: 3941314
    [Abstract] [Full Text] [Related]

  • 33. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR, Powell-Jones CH, Thomas CG, Nayfeh SN.
    Endocrinology; 1981 Nov 17; 109(5):1578-89. PubMed ID: 6271536
    [Abstract] [Full Text] [Related]

  • 34. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec 17; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 35. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs.
    Csernansky JG, Csernansky CA, Hollister LE.
    Experientia; 1985 Nov 15; 41(11):1419-21. PubMed ID: 4065296
    [Abstract] [Full Text] [Related]

  • 36. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.
    Battaglia G, Shannon M, Titeler M.
    J Neurochem; 1984 Nov 15; 43(5):1213-9. PubMed ID: 6491656
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.
    Harrold MW, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD.
    J Med Chem; 1989 Apr 15; 32(4):874-80. PubMed ID: 2522993
    [Abstract] [Full Text] [Related]

  • 38. Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.
    Memo M, Lovenberg W, Hanbauer I.
    Proc Natl Acad Sci U S A; 1982 Jul 15; 79(14):4456-60. PubMed ID: 6956874
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.